ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Above 50 Day Moving Average of $54.20

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBGet Free Report)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $54.20 and traded as high as $60.00. ProShares Ultra Nasdaq Biotechnology shares last traded at $59.26, with a volume of 5,243 shares trading hands.

ProShares Ultra Nasdaq Biotechnology Trading Down 0.8 %

The stock’s fifty day moving average price is $54.20 and its 200-day moving average price is $54.91.

ProShares Ultra Nasdaq Biotechnology Announces Dividend

The firm also recently declared a dividend, which was paid on Wednesday, March 27th. Stockholders of record on Thursday, March 21st were paid a $0.0403 dividend. The ex-dividend date of this dividend was Wednesday, March 20th.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Texas Capital Bank Wealth Management Services Inc purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 1st quarter worth approximately $288,000. Westwood Wealth Management purchased a new position in shares of ProShares Ultra Nasdaq Biotechnology during the first quarter worth $575,000. Toth Financial Advisory Corp grew its stake in shares of ProShares Ultra Nasdaq Biotechnology by 132.3% in the first quarter. Toth Financial Advisory Corp now owns 26,111 shares of the exchange traded fund’s stock valued at $1,502,000 after buying an additional 14,870 shares in the last quarter. Clarity Capital Partners LLC acquired a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the fourth quarter valued at $201,000. Finally, IMC Chicago LLC purchased a new stake in shares of ProShares Ultra Nasdaq Biotechnology in the 4th quarter valued at $2,435,000.

About ProShares Ultra Nasdaq Biotechnology

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

See Also

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.